Publications by authors named "Stephane Supiot"

Claim this Profile
R
Role of radiotherapy in the management of bladder cancer: Recommendations of the Société française de radiothérapie oncologique, 2025 update.
Paul Sargos, Louis-Marie Sauvage, Jonathan Khalifa, Olivier Riou, David Azria, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for external radiotherapy and brachytherapy procedures: 4th edition.
Igor Latorzeff, Alizée Camps-Malea, Véronique Vendrely, David Azria, Laure Parent, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of radiotherapy in the management of testicular cancer: Recommendations from the French society for radiation oncology.
Charles Raynaud, Stéphane Supiot, Jennifer Le Guévelou, Pierre Blanchard, Jihane Boustani

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of radiotherapy in the management of primary renal cell carcinoma: Recommendations from the Société française de radiothérapie oncologique (SFRO, the French society for radiation oncology).
Nicolas Benziane-Ouaritini, Jennifer Le Guevelou, Stéphane Supiot, Mario Terlizzi, Olivier Chapet

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding management strategies for metastatic hormone-sensitive prostate cancer: A multidisciplinary survey in France.
Aurélien Gobert, Marc-Olivier Timsit, Pierre Blanchard, Xavier Artignan, Gilles Crehange, Stéphane Supiot

Fr J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidisciplinary approach to managing non-metastatic castration resistant prostate cancer: Insights from a national practice survey.
Paul Sargos, Charles Merlin, François Rozet, Myriam Chebbah, Solenn Le Clanche, Stéphane Supiot

Fr J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes.
Guillaume Ploussard, Michaël Baboudjian, Eric Barret, Laurent Brureau, Charles Dariane, Stéphane Supiot

Fr J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for penile cancers: 2025 update.
Geneviève Loos, Alexandre Escande, Sabrina Aziez, Vincent Marchesi, Paul Sargos, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial.
Thomas Zilli, Dirk Böhmer, Andreas Roeder, David Lauffer, Ana Elena Villafranca Iturre, Stéphane Supiot

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.
Yuedan Zhou, Alexandre Escande, David Pasquier, Cyrus Chargari, Myriam Ayadi, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RadioTransNet: Preclinical research network coordinated by the Société française de radiothérapie oncologique and Société française de physique médicale, 2025 update.
Émilie Bayart, Marc Benderitter, François Boussin, Jacques Balosso, Éric Deutsch, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External beam radiotherapy for prostatic cancers: 2025 update.
Igor Latorzeff, Alizée Camps-Maléa, Christophe Hennequin, Olivier Chapet, David Pasquier, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy of bone metastases: 2025 update.
Nicolas Martz, Jean Christophe Faivre, Guillaume Beldjoudi, Antoine Arnaud, Jérôme Chamois, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reirradiation of lung, breast and bone tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.
Yuedan Zhou, Alexandre Escande, Arnaud Beddok, Cyrus Chargari, Marie-Pierre Sunyach, Stéphane Supiot

Cancer Radiother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points.
Neal D Shore, Ugo De Giorgi, Ronald F Tutrone, James L Bailen, Erik P M Roos, Stéphane Supiot

J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial.
Nicolas Demogeot, Paul Sargos, Julia Salleron, Stéphane Guérif, Renaud de Crevoisier, Stéphane Supiot

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour cells for the prediction of the response to radiation therapy in prostate cancer.
Camille Landry, Daria Klusa, Denis Cochonneau, Stéphane Supiot, Dominique Heymann

Br J Radiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial.
Adrien Rousseau, Maryam Karimi, Stefan Michiels, Guilhem Roubaud, Xavier Maldonado, Stephane Supiot

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RecoRad™ 4th edition: The Société française de radiothérapie oncologique's "Recommendations" Commission-driven RecoRad™ 2025 updated version.
Igor Latorzeff, Stéphane Supiot

Cancer Radiother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP).
Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, Neal D Shore, Ashley E Ross, Stephane Supiot

Future Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Federico Iori, Emanuele Alì, and Cinzia Iotti's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019.
Nicolas Demogeot, Stéphane Supiot, Paul Sargos

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Mattia Longoni, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019.
Nicolas Demogeot, Stéphane Supiot, Paul Sargos

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic education for patients with prostate cancer: Feasibility, implementation, and preliminary outcomes.
Thérèse Valy-Foti, Elvire Martin-Mervoyer, Josselin Sebille, Sophie Allain, Stéphane Supiot

Cancer Radiother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Organs-at-Risk for Radiation Therapy Following Radical Prostatectomy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
Jennifer Le Guevelou, Thomas Zilli, Arthur Peyrottes, Luc Beuzit, Ludovic Ferretti, Stephane Supiot

Pract Radiat Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid ReGex and Natural Language Inference Model as a Zero-Shot Classifier for Extracting Data From Medical Reports.
Nicolas Wagneur, Olivier Capitain, Stéphane Supiot, Florent Le Borgne, François Bocquet

JCO Clin Cancer Inform· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis